Cytogenetics, cytogenomics and cancer: 2004 Update;De la cytogénétique à la cytogénomique des tumeurs: Le point en 2004

Bulletin du Cancer

Volumn 91, Issue 1, 2004, Pages 29-43

  Bernheim, Alain ^a   Huret, Jean Louis ^a,b   Guillaud Bataille, Marine ^a   Brison, Olivier ^a   Couturier, Jérôme ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c INSTITUT CURIE   (France)

Author keywords

Cytogenetic; Cytogenomic; Tumor

Indexed keywords

CANCER; CANCER GROWTH; CARCINOGENESIS; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DNA MICROARRAY; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMICS; HUMAN; KARYOTYPE; MORPHOLOGY; PROGNOSIS; REVIEW;

CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; DATABASES, GENETIC; GENOME, HUMAN; GENOMICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 1242331521     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Boveri T. In Zur Frage der Entstehung Maligner Tumoren. Jena : Gustav Fisher ; 1914.
2. Balmain A. Cancer genetics: from Boveri and Mendel to microarrays. Nature Rev Cancer 2001 ; 1 : 77-82.
3. Huret J, Dessen P, Bernheim A. Atlas of genetics and cytogenetics in oncology and haematology 2003. http://www.infobiogen.fr/services/chromcancer/
4. Mitelman F, Johansson B, Mertens F. Database of chromosome aberrations in cancer 2003. http://cgap.nci.nih.gov/Chromosomes/Mitelman
5. Vardiman J, Harris NL, Brunning R. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002 ; 100 : 2292-302.
6. Antonini P, Levy N, Caillou B, Venuat AM, Schlumberger M, Parmentier C, Bernheim A. Numerical aberrations, including trisomy 22 as the sole anomaly, are recurrent in follicular thyroid adenomas. Genes Chromosomes Cancer 1993 ; 8 : 63-6.
7. Vagner-Capodano AM, Zattara-Cannoni H, Quilichini B, Giocanti G. De la cytogénérique à la cytogénomique des tumeurs cérébrales : 1. Les médulloblastomes. Bull Cancer 2003 ; 90 : 315-8.
8. Stirewalt D, Radich J. The role of FLT3 in hematopoietic malignancies. Nature Rev Cancer 2003 ; 3 : 650-65.
9. Mitelman F. An international system fur human cytogenetic nomenclature. Basel : Karger ; 1995.
10. Croft JA, Bridger JM, Boyle S, Perry P, Teague P, Bickmore WA. Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 1999 ; 145 : 1119-31.
11. Cremer M, Kupper K, Wagler B, Wizelman L, von Hase J, Weiland Y, et al. Inheritance of gene density-related higher order chromatin arrangements in normal and rumor cell nuclei. J Cell Biol 2003 ; 162 : 809-20.
12. Trask B. Human cytogenetics: 46 chromosomes, 46 years and counting. Nature Rev Genet 2002 ; 3 : 769-78.
13. Bernheim A. De la cytogénétique à la cytogénomique des cancers. Bull Cancer 2002 ; 89 : 161-5.
14. NCI and NCBI. NCI and NCBI's SKY/M-FISH and CGH Database. http://www.ncbi.nlm.nih.gov/sky/skyweb.cgi, 2001.
15. Rocchi M. http://www.biologia.uniba.it/rmc/. 2003.
16. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992 ; 258 : 818-21.
17. Snijders A, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nature Genet 2001 ; 29 : 263-4.
18. Pierotti M. Chromosomal rearrangements in thyroid carcinomas : a recombination or death dilemma. Cancer Lett 2001 ; 166 : 1-7.
19. Fagin JA. Perspective : lessons learned from molecular genetic studies of thyroid cancer - insights into pathogenesis and tumor-specific therapeutic targets. Endocrinology 2002 ; 143 : 2025-8.
20. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, et al. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 2003 ; 88 : 5399-404.
21. Harrington L, Robinson M. Telomere dysfunction : multiple paths to the same end. Oncogene 2002 ; 21 : 592-7.
22. Albertson D, Collins C, McCormick F, Gray J. Chromosome aberrations in solid tumors. Nature Genet 2003 ; 34 : 369-76.
23. Brodeur GM. Neuroblastoma : biological insights into a clinical enigma. Nature Rev Cancer 2003 ; 3 : 203-16.
24. Bown N, Cotterill S, Latowska M, O'Neill S, Pearson A, Nicholson J, et al. Gain of chromosome arm 17q and adverse clinical outcome in neuroblastama. N Engl J Med 1999 ; 340 : 1954-61.
25. Meddeb M, Danglot G, Chudoba I, Venuat AM, Benard J, Avet-Loiseau H, et al. Additional copies of a 25 Mb chromosomal region originating from 17q23.1-17qter are present in 90 % of high-grade neuroblastomas. Genes Chromosomes Cancer 1996 ; 17 : 156-65.
26. Pedeutour F, Foa C. De la cytogénétique à la cytogénomique des tumeurs adypocytaires : tumeurs adipocytaires benignes. Bull Cancer 2002 ; 89 : 689-95.
27. Perissel B, Bernheim A, Couturier J, Fouilhoux G, Vago P, Groupe français d'oncologique. De la cytogénétique à la cytogénomique des cancers de la thyroïde. Bull Cancer 2002 ; 89 : 588-92.
28. Mehes G, Luegmayr A, Kornmuller R, Ambros IM, Ladenstein R, Gadner H, et al. Detection of disseminated tumor cells in neuroblastoma: 3 logs improvement in sensitivity by automatic immunofluorescence plus Fish (AIPF) analysis compared with classical bone marrow cytology. Am J Pathol 2003 ; 163 : 393-9.
29. Sandberg A. Cytogenetics and molecular genetics of bone and soft-tissue tumors. Am J Med Genet 2002 ; 115 : 189-93
30. Glukhova L, Goguel AF, Chudoba I, Angevin E, Pavon C, Terrier-Lacombe MJ, et al. Overrepresentation of 7q31 and 17q in renal cell carcinomas. Genes Chromosomes Cancer 1998 ; 22 : 171-8.
31. Schmidt L, JK, NN, et al. Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene 1999 ; 18 : 2343-50.
32. Perot C, Boccon-Gibod L, Bouvier R, Doz F, Fournet JC, Freneaux P, et al. Five new cases of juvenile renal cell carcinoma with translocations involving Xp11.2 : a cytogenetic and morphologic study. Cancer Genet Cytogenet 2003 ; 143 : 93-9.
33. Leonard C, Huret J, GFCO. De la cytogénétique à la cytogénomique des cancers de la vessie. Bull Cancer 2002 ; 89 : 166-73.